Kurma Partners
Kurma Partners is a leading European life sciences venture capital firm based in Paris. They specialize in therapeutics and digital health investments, with particular expertise in oncology, rare diseases, and platform technologies.
Location
Paris, France
Founded
2009
AUM
€500M+
Investment Range
€2M - €20M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c
Investment Thesis
Kurma Partners invests in innovative life sciences companies with strong science and potential for significant clinical and commercial impact. They focus on therapeutics and digital health across Europe, bringing deep scientific expertise and operational support to portfolio companies.
Team
Partners / Managing Directors (Health & Bio Focus)
- Rémi Droller - Managing Partner
- Vanessa Malier - Partner
- Thierry Laugel - Partner
Other Key Team Members
- Investment team includes PhDs and MDs with deep scientific expertise
Focus Areas
- Therapeutics (oncology, rare diseases)
- Digital health
- Platform technologies
- French life sciences ecosystem
- European biotech
- Gene therapy
Notable Exits
- Multiple European biotech exits through M&A and IPOs
- Strong track record in oncology investments
Sources
- https://www.kurmapartners.com
- https://www.kurmapartners.com/team
- PitchBook
- France Biotech